🇺🇸 FDA
Pipeline program

Lugol's Solution (1.5%)

ED102807

Unknown small_molecule active

Quick answer

Lugol's Solution (1.5%) for Esophageal Squamous Cell Neoplasm is a Unknown program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Esophageal Squamous Cell Neoplasm
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials